7 results on '"Beall RF"'
Search Results
2. The characteristics of patents impacting availability of biosimilars.
3. Identifying potential prescription drug product hopping.
4. Pre-market development times for biologic versus small-molecule drugs.
5. Tertiary patenting on drug-device combination products in the United States.
6. Will inter partes review speed US generic drug entry?
7. Which patent and where? Why international patent transparency by companies is needed for medicines.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.